SG11201902465TA - Inhibitors of mtor-deptor interactions and methods of use thereof - Google Patents
Inhibitors of mtor-deptor interactions and methods of use thereofInfo
- Publication number
- SG11201902465TA SG11201902465TA SG11201902465TA SG11201902465TA SG11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- deptor
- inhibitors
- pct
- rule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/84—Hydrazones having doubly-bound carbon atoms of hydrazone groups being part of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
- C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662418362P | 2016-11-07 | 2016-11-07 | |
PCT/US2017/060116 WO2018085753A1 (en) | 2016-11-07 | 2017-11-06 | Inhibitors of mtor-deptor interactions and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201902465TA true SG11201902465TA (en) | 2019-05-30 |
Family
ID=62076420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201902465TA SG11201902465TA (en) | 2016-11-07 | 2017-11-06 | Inhibitors of mtor-deptor interactions and methods of use thereof |
Country Status (13)
Country | Link |
---|---|
US (1) | US20190330142A1 (ja) |
EP (1) | EP3535239A1 (ja) |
JP (1) | JP2019535815A (ja) |
KR (1) | KR20190114955A (ja) |
CN (1) | CN109952287A (ja) |
AU (1) | AU2017355566A1 (ja) |
BR (1) | BR112019008606A2 (ja) |
CA (1) | CA3039070A1 (ja) |
IL (1) | IL266344A (ja) |
MX (1) | MX2019005294A (ja) |
RU (1) | RU2019112671A (ja) |
SG (1) | SG11201902465TA (ja) |
WO (1) | WO2018085753A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102114899B1 (ko) * | 2020-02-26 | 2020-05-26 | 가천대학교 산학협력단 | mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물 |
KR102147491B1 (ko) * | 2020-05-29 | 2020-08-25 | 가천대학교 산학협력단 | DEPTOR 단백질 억제제 또는 mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882152A (en) * | 1970-09-09 | 1975-05-06 | Air Prod & Chem | Beta cyclopentadienyl hydrazides and carbazates |
-
2017
- 2017-11-06 CA CA3039070A patent/CA3039070A1/en not_active Abandoned
- 2017-11-06 JP JP2019545716A patent/JP2019535815A/ja active Pending
- 2017-11-06 CN CN201780068696.3A patent/CN109952287A/zh active Pending
- 2017-11-06 KR KR1020197013668A patent/KR20190114955A/ko unknown
- 2017-11-06 RU RU2019112671A patent/RU2019112671A/ru not_active Application Discontinuation
- 2017-11-06 MX MX2019005294A patent/MX2019005294A/es unknown
- 2017-11-06 WO PCT/US2017/060116 patent/WO2018085753A1/en active Application Filing
- 2017-11-06 EP EP17867401.6A patent/EP3535239A1/en not_active Withdrawn
- 2017-11-06 AU AU2017355566A patent/AU2017355566A1/en not_active Abandoned
- 2017-11-06 US US16/347,295 patent/US20190330142A1/en not_active Abandoned
- 2017-11-06 BR BR112019008606A patent/BR112019008606A2/pt not_active Application Discontinuation
- 2017-11-06 SG SG11201902465TA patent/SG11201902465TA/en unknown
-
2019
- 2019-04-30 IL IL266344A patent/IL266344A/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2019112671A (ru) | 2020-12-07 |
JP2019535815A (ja) | 2019-12-12 |
US20190330142A1 (en) | 2019-10-31 |
CA3039070A1 (en) | 2018-05-11 |
AU2017355566A1 (en) | 2019-04-04 |
CN109952287A (zh) | 2019-06-28 |
BR112019008606A2 (pt) | 2019-07-09 |
IL266344A (en) | 2019-06-30 |
KR20190114955A (ko) | 2019-10-10 |
MX2019005294A (es) | 2019-10-14 |
EP3535239A1 (en) | 2019-09-11 |
WO2018085753A1 (en) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201811490XA (en) | Cd3 binding antibodies | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201909949XA (en) | Targeted immunotolerance | |
SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
SG11201908560SA (en) | Heterocyclic compounds useful as dual atx/ca inhibitors | |
SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
SG11201903697WA (en) | Liver organoid compositions and methods of making and using same | |
SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
SG11201804132UA (en) | Eif4-a-inhibiting compounds and methods related thereto | |
SG11201803906PA (en) | Control of cellular redox levels | |
CA3025288C (en) | Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers | |
SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
SG11201900634VA (en) | Chimeric antigen receptor | |
SG11201908472VA (en) | Compositions and methods for activating nk cells | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
SG11201908929VA (en) | Synthekine compositions and methods of use | |
SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201909003YA (en) | Integrated vascular access device and anchor pad | |
SG11201907196YA (en) | Composition and methods for preventing radiation injury and promoting tissue regeneration | |
SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof |